Juliane Medler

Wuerzburg, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Corrigendum: A TNFR2-specific TNF fusion protein with improved in vivo activity.

Corrigendum: A TNFR2-specific TNF fusion protein with improved in vivo activity.

Journal: Frontiers in immunology
Published: December 08, 2023

Generic design principles for antibody-based tumour necrosis factor (TNF) receptor 2 (TNFR2) agonists with FcγR-independent agonism.

Generic design principles for antibody-based tumour necrosis factor (TNF) receptor 2 (TNFR2) agonists with FcγR-independent agonism.

Journal: Theranostics
Published: March 17, 2023

Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy.

Tumor Necrosis Factor Receptor 2 (TNFR2): An Emerging Target in Cancer Therapy.

Journal: Cancers
Published: April 18, 2022

A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity.

A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity.

Journal: Frontiers in immunology
Published: March 02, 2022

CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism.

CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism.

Journal: Theranostics
Published: August 16, 2021

Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans.

Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans.

Journal: Blood advances
Published: January 25, 2021

Membrane lymphotoxin-α2β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist.

Membrane lymphotoxin-α2β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist.

Journal: Cell death & disease
Published: November 19, 2020

Analysis of Ligand-Receptor Interactions Using Bioluminescent TNF Superfamily (TNFSF) Ligand Fusion Proteins.

Analysis of Ligand-Receptor Interactions Using Bioluminescent TNF Superfamily (TNFSF) Ligand Fusion Proteins.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 13, 2020

Analysis of FcγR-Dependent Agonism of Antibodies Specific for Receptors of the Tumor Necrosis Factor (TNF) Receptor Superfamily (TNFRSF).

Analysis of FcγR-Dependent Agonism of Antibodies Specific for Receptors of the Tumor Necrosis Factor (TNF) Receptor Superfamily (TNFRSF).

Journal: Methods in molecular biology (Clifton, N.J.)
Published: November 13, 2020

CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism.

CD40- and CD95-specific antibody single chain-Baff fusion proteins display BaffR-, TACI- and BCMA-restricted agonism.

Journal: mAbs
Published: August 26, 2020

Single-molecule imaging reveals the oligomeric state of functional TNFα-induced plasma membrane TNFR1 clusters in cells.

Single-molecule imaging reveals the oligomeric state of functional TNFα-induced plasma membrane TNFR1 clusters in cells.

Journal: Science signaling
Published: January 16, 2020

Quantitative single-molecule imaging of TNFR1 reveals zafirlukast as antagonist of TNFR1 clustering and TNFα-induced NF-ĸB signaling.

Quantitative single-molecule imaging of TNFR1 reveals zafirlukast as antagonist of TNFR1 clustering and TNFα-induced NF-ĸB signaling.

Journal: Journal of leukocyte biology
Published: November 01, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026